DAVID BAILEY: Open Payments
NPI 1144742453 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,043 in 51 payments from 14 companies in 2025. Trend: 2023 $2,220 · 2024 $2,600 · 2025 $1,043
Food & beverage: $1,043
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $222 |
| Lilly USA, LLC | 7 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $133 |
| Janssen Biotech, Inc. | 6 | $118 |
| Madrigal Pharmaceuticals | 4 | $84 |
| Ardelyx, Inc. | 3 | $70 |
| PFIZER INC. | 4 | $68 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Celltrion USA Inc. | 2 | $44 |
| QOL Medical, LLC | 1 | $28 |
Products named: OMVOH, ENTYVIO, RINVOQ, TREMFYA, REZDIFFRA, DUPIXENT, IBSRELA, XELJANZ.
Industry payments across AL — which companies pay providers there.
